U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Advisory Committees
  3. Committees and Meeting Materials
  4. Human Drug Advisory Committees
  5. Peripheral and Central Nervous System Drugs Advisory Committee
  6. Peripheral and Central Nervous System Drugs Advisory Committee Roster
  1. Peripheral and Central Nervous System Drugs Advisory Committee

Peripheral and Central Nervous System Drugs Advisory Committee Roster

Applying for Membership on FDA Advisory Committees

As part of the Food and Drug Administration’s (FDA’s) ongoing efforts to recruit qualified experts with minimal conflicts of interest who are interested in serving on FDA advisory committees, FDA is requesting nominations for members to serve on its advisory committees. More information (2/27/2007)

Current Number of Vacancies = 5
Note, one or more vacancies may be in the nomination process or a final appointment may have been made.

Chairperson

Thomas J. Montine, MD, PhD
Expertise: Neuropathology
Term: 12/1/2021 – 1/31/2026
Chair, Department of Pathology
Stanford Medicine Endowed Professor
Stanford University School of Medicine
300 Pasteur Drive, Suite L235
Stanford, California 94305

Designated Federal Officer 
Jessica Seo, PharmD, MPH
Division of Advisory Committee and Consultant Management
Office of Executive Programs
Center for Drug Evaluation and Research
Food and Drug Administration
10903 New Hampshire Avenue
Silver Spring, Maryland 20993-0002
Phone: (301) 796-9001 Fax: (301) 847-8533
E-mail: PCNS@fda.hhs.gov


Robert C. Alexander, MD
Expertise: Psychiatry/Drug Development
Term: 12/1/2021 – 1/31/2026
Chief Scientific Officer Alzheimer’s Prevention Initiative
Banner Alzheimer’s Institute
Research Professor, Department of Psychiatry
University of Arizona College of Medicine – Phoenix
Phoenix, Arizona 85006

Liana G. Apostolova, MD, MSc, FAAN
Expertise: Neurology
Term: 12/1/2021 – 1/31/2026
Distinguished Professor in Neurology
Barbara and Peer Baekgaard Chair in
Alzheimer’s Disease Research
Professor in Radiology and Medical and
Molecular Genetics
Indiana University School of Medicine
Indiana Alzheimer's Disease Center
355 W 16th Street, Suite 4019
Indianapolis, Indiana 46202


Merit E. Cudkowicz, MD
Expertise: Neurology
Term: 12/1/2021 – 1/31/2025
Julieanne Dorn Professor of Neurology
Harvard Medical School
Chair, Department of Neurology
Director, Sean M. Healey & AMG Center for ALS
Massachusetts General Hospital
55 Fruit Street, WACC 720
Boston, Massachusetts 02114

Paul M. Kirsch**
Expertise: Drug Regulatory Affairs
Term: 1/17/2024 – 10/31/2027
Vice President, Regulatory Affairs
Harmony Biosciences, LLC
630 W. Germantown Pike, Suite 215
Plymouth Meeting, Pennsylvania 19462

Richard J. Kryscio, PhD
Expertise: Biostatistics
Term: 5/9/2024 – 1/31/2026
Professor, Statistics and Biostatistics
University of Kentucky
Sanders-Brown Center on Aging
422 Healthy Kentucky Research Building
Lexington, Kentucky 40536

Tanya Simuni, MD
Expertise: Neurology
Term: 5/25/2024 – 1/31/2028
Arthur C. Nielsen Professor of Neurology
Division Head, Parkinson's Disease and Movement Disorders Center
Northwestern University Feinberg School of Medicine
Abbott Hall 11th Floor
710 North Lake Shore Drive
Chicago, Illinois 60611

David Weisman, MD
Expertise: Neurology
Term: 5/9/2024 – 1/31/2028
Director, ANA Clinical Research Center
Abington Neurologic Associates
1151 Old York Road, #200
Abington, Pennsylvania 19001

 


*Consumer Representative (Vacant)
**Industry Representative (non-voting)

 

Back to Top